Makers of organoids and cell models cheered the decision and said it will bolster the development of precision medicines, ...

Charles River Laboratories, a leading provider of preclinical drug development services, has reported impressive results in ...

The impetus: an announcement from the US Food and Drug Administration in early April indicating that the agency plans to phase out animal tests—a longtime cornerstone of preclinical drug testing ...

Transneural Therapeutics, Inc. (Transneural), a preclinical-stage biotechnology company aiming to transform the treatment of ...

Thermo Fisher Scientific is employing an enhanced platform technology and a new CHO K-1 cell line that can reduce timelines ...

Pre-Clinical Drug Discovery Services Market to grow through 2035, driven by rising chronic diseases and increased outsourcing of early-stage R&D.

The objective of the Preclinical Development Program (PDEV) is to accelerate completion of preclinical development, FDA IND clearance, and clinical trial startup for stem cell-based and genetic ...